Posts by Sandra Ansanay-Alex
Timeline Wins $5.3 Million Court Judgment Against Fake Urolithin A Sellers
Timeline (Amazentis SA), the Lausanne-Based life-sciences company behind the postbiotic ingredient Urolithin A and its branded form Mitopure®, has secured a major legal victory in the United States. On July 15, 2026, the U.S. District Court for the District of Massachusetts permanently banned 19 online sellers from marketing or selling fraudulent Urolithin A products and…
Read MoreHAYA Therapeutics granted Fast Track designation by the FDA for HTX-001
HAYA Therapeutics SA, a clinical-stage biotechnology company based in Lausanne and San Diego, announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to HTX-001, its therapeutic candidate for symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM). HTX-001 is an antisense oligonucleotide designed to reduce the expression of *WISPER*, a cardiac stress-specific long non-coding…
Read MoreGlobal Leverage Award 2026
Apply before 15 August 2026 for the Global Leverage Award 2026, a partnership between CorporateConnections Switzerland and EPFL, for startups and scaleups developing human-centered innovations across sectors including health & longevity, future of work, education & neurodiversity, inclusion & accessibility, digital trust, and social connection, among others. Projects are evaluated on real human impact, viability,…
Read MoreAB2 Bio Secures $30 Million as Nippon Shinyaku Exercises US Commercialization Rights for Tadekinig Alfa
AB2 Bio, a Swiss Health Valley and EPFL based company, has announced that Nippon Shinyaku has exercised its exclusive option to commercialize Tadekinig alfa in the United States, following positive exchanges with the FDA. Under the agreement, AB2 Bio will receive an upfront payment of $30 million and is eligible for up to $600 million…
Read MoreHeroSupport Starts Clinical Study With NYU Grossman School of Medicine
HeroSupport SA is a UNIGE and HUG spin out and created VENUS SHELL™ , a 3D-printed support that enables accurate, reproducible, and more comfortable positioning during radiation therapy for breast cancer patients. HeroSupport SA is advancing patient immobilisation in prone breast cancer radiotherapy. The CE-marked VENUS SHELL™ is a patient-specific, 3D-printed support that enables accurate,…
Read MoreThe Gate Challenge
Apply for the Gate Challenge for Healthy Aging. The Programme starts on 1st September 2026! Are you a medtech, biotech, foodtech or climate related company looking to expand in China ? The Gate Challenge is bridging Swiss & Chinese Innovation for Healthy Aging. Selected startups will have their on-site costs fully covered and can tailor their participation, whether…
Read MoreImpli and Molesense Selected for Germany’s SPRIND Continuous Hormone Monitoring Challenge
MoleSense and Impli, two startups based at Biopôle near Lausanne, have both been selected by Germany’s Federal Agency for Breakthrough Innovation (SPRIND) for its Continuous Hormone Monitoring Challenge — a three-year programme backing biosensor technologies capable of tracking at least four hormones continuously over seven days, with up to €1.5 million in Stage 1 funding…
Read MorePlanimetrics Receives CHF 40,000 from Venture Kick
Planimetrics, formerly Laxiped, is a life-sciences project, spun out University of Geneva (UNIGE) and Assal Center, working on a solution to support foot and ankle surgeons diagnostics and decicion-making. First ray instability is a foot condition still diagnosed mainly through physical examination — a gap Planimetrics is working to close. The company has been awarded…
Read MoreThree Wins for the Swiss Health Valley: Recognition for Unboound, DIVERSSITY and Prof. Nicolas Winssinger
From clinical innovation to fundamental science, each of these Swiss Health Valley entrepreneurs and researchers were recognised at the highest level their respective field : ORL, AI-Driven Mental Health therapy and and Medicinal Chemistry. Dr. Julien Wen Hsieh wins the Grand Prix 2026 of the Swiss Society of ORL Dr. Julien Wen Hsieh, CEO and…
Read MoreMasimo Wins its Legal Battle Against Apple and is Set to Receive a Cheque for $634 million
Masimo, which has been headquartered in Neuchâtel since 2008 and employs over 100 staff there at the heart of the Swiss Health Valley, has just won one of the most closely watched legal cases in the technology industry. The US courts have definitively dismissed Apple’s appeal, confirming that the Californian firm must pay $634 million…
Read More